文献速递血液淋巴病理细胞病理与分子病理

髓系肿瘤皮肤表现形态免疫表型多样但与骨髓共享克隆突变

Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
PubMed 文献 · Mod Pathol · 2023-10-13

本研究对17例皮肤髓系或组织细胞-树突细胞肿瘤患者的配对皮肤与外周血/骨髓样本进行分子分析,发现皮肤与骨髓肿瘤共享克隆突变,c-AML中NPM1突变常见,组织细胞-树突细胞肿瘤共享ASXL1、TET2、SRSF2等驱动突变。

要点

  • 皮肤髓系肿瘤形态免疫表型多样,但与骨髓共享克隆突变。
  • c-AML中70%有NPM1突变,且多数骨髓受累者共享克隆突变。
  • 皮肤组织细胞-树突细胞肿瘤共享ASXL1、TET2、SRSF2驱动突变。

核心结论

  • 皮肤髓系肿瘤形态免疫表型广泛多样,但与骨髓肿瘤共享祖先克隆突变。

研究设计与样本

  • 对17例皮肤髓系或组织细胞-树突细胞肿瘤患者的配对皮肤与外周血/骨髓样本进行分子分析。

主要发现

  • 10例c-AML中7例(70%)有骨髓受累,且7例(100%)皮肤与骨髓共享克隆突变。
  • c-AML中7/10(70%)检出NPM1突变,1例KMT2A重排,1例inv(16)。
  • 3例朗格汉斯细胞肿瘤、2例BPDCN及1/2例其他皮肤树突细胞肿瘤皮肤与骨髓共享突变。
  • 皮肤与c-AML共享相同创始驱动突变,以NPM1、DNMT3A和单核分化相关易位为主。
  • 皮肤组织细胞-树突细胞肿瘤共享ASXL1、TET2和/或SRSF2创始驱动突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this study, we performed a comprehensive molecular analysis of paired skin and peripheral blood/bone marrow (BM) samples from 17 patients with cutaneous myeloid or cutaneous histiocytic-dendritic neoplasms. The cutaneous manifestations included 10 patients with cutaneous acute myeloid leukemia (c-AML), 2 patients with full or partial Langerhans cell differentiation, 2 patients with blastic plasmacytoid dendritic cell neoplasms (BPDCN), 1 patient with both Langerhans cell differentiation and BPDCN, and 2 patients with full or partial indeterminate dendritic cell differentiation. Seven of the 10 c-AML patients (70%) exhibited concurrent or subsequent marrow involvement by acute myeloid leukemia, with all 7 cases (100%) demonstrating shared clonal mutations in both the skin and BM. However, clonal relatedness was documented in one additional case that never had any BM involvement. Nevertheless, NPM1 mutations were identified in 7 of the 10 (70%) of these c-AML cases while one had KMT2A rearrangement and one showed inv(16). All 3 patients (100%) with Langerhans cell neoplasms, 2 patients with BPDCN (100%), and one of the 2 patients (50%) with other cutaneous dendritic cell neoplasms also demonstrated shared mutations between the skin and concurrent or subsequent myeloid neoplasms. Both BM and c-AML shared identical founding drivers, with a predominance of NPM1, DNMT3A, and translocations associated with monocytic differentiation, with common cutaneous-only mutations involving genes in the signal transduction and epigenetic pathways. Cutaneous histiocytic-dendritic neoplasms shared founding drivers in ASXL1, TET2, and/or SRSF2. However, in the Langerhans cell histiocytosis or histiocytic sarcoma cases, there exist recurrent secondary RAS pathway hits, whereas cutaneous BPDCN cases exhibit copy number or structural variants. These results enrich and broaden our understanding of clonally related cutaneous manifestations of myeloid neoplasms and further illuminate the highly diverse spectrum of morphologic and immunophenotypic features they exhibit.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Sadigh S, DeAngelo DJ, Garcia JS, et al. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. Mod Pathol. 2023. PMID: 37839675. doi:10.1016/j.modpat.2023.100352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。